Skip to content

Contact +44 (0) 20 7060 7474 email us

Diabetes

The Future of The Diabetes Care Devices Market to 2016

The Key Demand Drivers Remain Intact

Publication Date January 2010
Publisher GBI Research
Product Type Report
Pages 116
ISBN Number not applicable
Product Code GBI00019

Price

£2,310.00
approximately: $3,498 | €2,578

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

GBI Research's new report, "The Future of the Diabetes Care Devices Market to 2016 - The Key Demand Drivers Remain Intact" provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories - glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

  • Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Global Market size and company share data for three diabetes care devices market categories - glucose monitoring and insulin delivery.
  • Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
  • Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
  • Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical.
  • Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What's the next big thing in the diabetes care devices market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

Contents

  • 1 Table of Contents
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction and Overview
    • 2.1 Type 1 Diabetes
    • 2.2 Type 2 Diabetes
    • 2.3 Diabetes Accentuating Cardiovascular Disease
      • 2.3.1 Atherosclerosis
      • 2.3.2 Diabetic Cardiomyopathy
      • 2.3.3 Stroke
      • 2.3.4 Renal Disease
    • 2.4 Diabetes a Burden on Healthcare Spending
    • 2.5 Prevalence and Incidence of Diabetes
      • 2.5.1 Global
      • 2.5.2 Diabetes Prevalence in Developing Nations
  • 3 Diabetes Care Devices Market: Market Characterization
    • 3.1 Global Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
    • 3.2 Global Diabetes Care Devices Market, Revenue Forecasts ($m), 2009 - 2016
    • 3.3 Diabetes Care Devices, Key Market Trends
      • 3.3.1 Home Healthcare Driving Growth in the Diabetes Care Devices Market
      • 3.3.2 Brand Loyalty in Diabetes Care Devices: Hard To Achieve
      • 3.3.3 Reimbursement Issues Restraining the Market
      • 3.3.4 Drug Stores to Remain the Major Distribution Channels
    • 3.4 Diabetes Care Devices: Technological Trends
      • 3.4.1 Enhancing Life
      • 3.4.2 Continuous Glucose Monitoring (CGM)
      • 3.4.3 Disposable Insulin Pumps
      • 3.4.4 Pain Free Monitoring Devices Will Drive Future Growth in the Diabetes Care Device Market
      • 3.4.5 Increasing Demand for Pain Free Insulin Delivery Devices
      • 3.4.6 Remote Monitoring: Increasing Diabetic Compliance
    • 3.5 Diabetes Care Devices, Market Drivers
      • 3.5.1 New Technologies to Boost Sales
      • 3.5.2 Increasing Prevalence of Diabetes to Boost Sales
      • 3.5.3 The Increasing Ageing Population of the World to Increase Patient Population
      • 3.5.4 Introduction of New Generation Devices to Drive the Glucose Monitoring Market
      • 3.5.5 Increase in Awareness of Better Diabetes Management
      • 3.5.6 Lifestyle Changes Bringing About the Increase in Disease Prevalence
      • 3.5.7 Product Innovation to Increase Acceptance
    • 3.6 Restraints
      • 3.6.1 Lack of Affordability and Awareness in Developing Nations
      • 3.6.2 Lack of Reimbursement for New Technologies
      • 3.6.3 Low diagnosis rate
      • 3.6.4 Low Patient Compliance
      • 3.6.5 Overall Cost Is a Restraint for Insulin Pens And Pumps
      • 3.6.6 Other Factors Restraining the Diabetes Care Devices Market
      • 3.6.7 Low Market Penetration Affecting Growth
    • 3.7 Global Diabetes Care Devices Market, Key Company Shares (%), 2008
  • 4 Global Diabetes Care Devices Market: Cross-Segment Market Analysis and Forecasts
    • 4.1 Glucose Monitoring Market
      • 4.1.1 Global Glucose Monitoring Market, Revenues ($m), 2002 - 2009
      • 4.1.2 Global Glucose Monitoring Market, Revenue Forecasts ($m), 2009 - 2016
      • 4.1.3 Market Drivers
      • 4.1.4 Market Restraints
      • 4.1.5 Glucose Monitoring Market, Revenue by Segment
      • 4.1.6 Blood Glucose Meters Market Dynamics
      • 4.1.7 Blood Glucose Test Strips Market Revenue
      • 4.1.8 Blood Glucose Test Strips Market Dynamics
    • 4.2 Insulin Delivery Devices
      • 4.2.1 Global Insulin Delivery, Revenue ($m), Global, 2002 - 2009
      • 4.2.2 Global Insulin Delivery, Revenue ($m), Global, 2009 - 2016
      • 4.2.3 Market Drivers
      • 4.2.4 Market Restraints
      • 4.2.5 Insulin Pumps Market Revenue
      • 4.2.6 Insulin Pumps, Revenue ($m), Global, Forecast
      • 4.2.7 Insulin Pumps Market Dynamics
      • 4.2.8 Insulin Pens Market Revenue
      • 4.2.9 Insulin Pens Market Dynamics
      • 4.2.10 Insulin Syringes, Market Revenue
      • 4.2.11 Insulin Syringes Market Dynamics
  • 5 Diabetes Care Devices: Competitive Landscape
    • 5.1 Insulin Delivery Competitive Landscape
      • 5.1.1 Strategic Competitor Assessment
      • 5.1.2 Insulin Delivery Devices, Company Share Analysis (%), 2008
    • 5.2 Key Companies
      • 5.2.1 Becton, Dickinson and Company
      • 5.2.2 Medtronic
      • 5.2.3 Novo Nordisk
      • 5.2.4 Others
      • 5.2.5 Insulet Corporation
      • 5.2.6 NiliMEDIX
      • 5.2.7 Medingo Ltd
      • 5.2.8 Debiotech S.A
      • 5.2.9 Phluid Corporation
      • 5.2.10 Ratio Inc
      • 5.2.11 Insuline Medical Ltd
      • 5.2.12 Aradigm Corporation
      • 5.2.13 MannKind Corporation
      • 5.2.14 Altea Therapeutics Corporation
    • 5.3 Glucose Monitoring Systems Market : Competitive Assessment
      • 5.3.1 Overview
      • 5.3.2 Strategic Competitor Assessment
      • 5.3.3 Glucose Monitoring Systems Company Shares 2008
      • 5.3.4 F. Hoffmann-La Roche Ltd
      • 5.3.5 LifeScan (Johnson & Johnson)
      • 5.3.6 Bayer Healthcare
      • 5.3.7 Abbott Laboratories
      • 5.3.8 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market
      • 5.3.9 OneTouch UltraMini
      • 5.3.10 Contour Meter
  • 6 Global Diabetes Care Devices Market: Cross-Country Analysis and Forecasts
    • 6.1 Revenues, By Country, 2002 - 2009
      • 6.1.1 The US Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.2 Canada Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.3 The UK Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.4 Germany Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.5 France Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.6 Italy Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.7 Spain Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.8 Japan Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.9 China Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.10 India Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.11 Australia Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
      • 6.1.12 Brazil Diabetes Care Devices Market, Revenues ($m), 2002 - 2009
    • 6.2 Revenue Forecasts, By Country, 2009 - 2016
      • 6.2.1 The US Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.2 Canada Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.3 The UK Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.4 Germany Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.5 France Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.6 Italy Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.7 Spain Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.8 Japan Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.9 China Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.10 India Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.11 Australia Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
      • 6.2.12 Brazil Diabetes Care Devices Market, Revenues ($m), 2009 - 2016
  • 7 Diabetes Care Devices: Pipeline Analysis
    • 7.1 Glucose Monitoring Key Pipeline Products
      • 7.1.1 Strategic Pipeline Assessment
      • 7.1.2 Glucose Monitoring Systems - Pipeline by Clinical Phase of Development
      • 7.1.3 Profiles of Promising Devices under Clinical Development
      • 7.1.4 Glucose Monitoring Systems Market: List of Pipeline Products
      • 7.1.5 Glucose Monitoring Systems Pipeline Product Summary by Product Type
      • 7.1.6 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems
      • 7.1.7 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems
      • 7.1.8 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems
    • 7.2 Implications for Future Market Competition
    • 7.3 Strategic Competitor Assessment
    • 7.4 Glucose Monitoring Systems Market: Emerging Companies
      • 7.4.1 Introduction
    • 7.5 Insulin Delivery Key Pipeline Products
      • 7.5.1 Overview
      • 7.5.2 Strategic Pipeline Assessment
      • 7.5.3 Insulin Delivery Devices - Clinical Pipeline by Mode of Insulin Delivery
    • 7.6 Insulin Delivery Devices - Pipeline by Clinical Phase of Development
    • 7.7 Insulin Delivery Devices Pipeline Product Summary
    • 7.8 Insulin Delivery Devices - Promising Devices under Clinical Development
      • 7.8.1 Closed-loop diabetes management system
      • 7.8.2 Paradigm Veo System
      • 7.8.3 AERx insulin Diabetes Management System
      • 7.8.4 Insulin Delivery Devices - Future Market Competition
      • 7.8.5 Strategic Competitor Assessment
    • 7.9 Reimbursement for Insulin Delivery Devices
  • 8 Global Diabetes Care Devices Market: Consolidation Landscape
    • 8.1 Deal Analysis-Q1 2009
      • 8.1.1 Diabetes Care Devices- Deals of Quarter 1
    • 8.2 Deal Analysis Q2 2009
      • 8.2.1 Diabetes Care Devices - Deals of Quarter 2
    • 8.3 Deal Analysis Q3 2009
      • 8.3.1 Diabetes Care Devices - Deals of the Quarter 3
    • 8.4 Deal Analysis - October 2009
    • 8.5 Deal Analysis - December 2009
  • 9 Appendix
    • 9.1 Decision Support Database
      • 9.1.1 Complications with Diabetes
    • 9.2 Diabetes Care Devices: Definitions
      • 9.2.1 Glucose Monitoring
      • 9.2.2 Insulin Delivery
    • 9.3 Methodology
      • 9.3.1 Secondary Research
      • 9.3.2 Primary Research
      • 9.3.3 Models
      • 9.3.4 Forecasts
      • 9.3.5 Expert Panels
    • 9.4 Contact Us
    • 9.5 Disclaimer
  • 1.1 List of Tables
    • Table 1: Diabetes Mellitus, Estimated Patient Population ('000's), 2030
    • Table 2: Diabetes Care Devices, Revenue ($m), Global, 2002 - 2009
    • Table 3: Diabetes Care Devices, Revenue ($m), Global, 2009 - 2016
    • Table 4: Total Cost, Traditional Glucose Meter Vs Continuous Glucose Monitor
    • Table 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 - 2009
    • Table 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 - 2015
    • Table 7: Non Invasive Glucose Monitoring Products
    • Table 8: Pain Free Insulin Delivery Products, 2009
    • Table 9: Prevalence Estimates of Diabetes, Global, 2030
    • Table 10: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Age Group, US, 2007
    • Table 11: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Gender, US, 2007
    • Table 12: Population Over the age of 65 ('000's), 2005 - 2010
    • Table 13: Glucose Monitoring, Revenue ($m), Global, 2002 - 2009
    • Table 14: Glucose Monitoring, Revenue ($m), Global, 2009 - 2016
    • Table 15: Blood Glucose Meters, Revenue ($m), Global, 2000 - 2009
    • Table 16: Blood Glucose Meters, Revenue ($m), Global, 2009 - 2016
    • Table 17: Blood Glucose Test Strips, Revenue ($m), Global, 2002 - 2009
    • Table 18: Blood Glucose Test Strips, Revenue ($m), Global, 2009 - 2016
    • Table 19: Comparison of Insulin Delivery Devices
    • Table 20: Insulin Delivery, Revenue ($m), Global, 2002 - 2009
    • Table 21: Insulin Delivery, Revenue ($m), Global, 2009 - 2016
    • Table 22: Insulin Pumps, Revenue ($m), Global, 2002 - 2009
    • Table 23: Insulin Pumps, Revenue ($m), Global, 2009 - 2016
    • Table 24: Insulin Pens, Revenue ($m), Global, 2002 - 2009
    • Table 25: Insulin Pens, Revenue ($m), Global, 2009 - 2016
    • Table 26: Insulin Syringes, Revenue ($m), Global 2002 - 2009
    • Table 27: Insulin Syringes, Revenue ($m), Global 2009 - 2016
    • Table 28: Diabetes Care Devices Market, Revenue ($m), US, 2002 - 2009
    • Table 29: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 - 2009
    • Table 30: Diabetes Care Devices Market, Revenue ($m), UK, 2002 - 2009
    • Table 31: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 - 2009
    • Table 32: Diabetes Care Devices Market, Revenue ($m), France, 2002 - 2009
    • Table 33: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 - 2009
    • Table 34: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 - 2009
    • Table 35: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 - 2009
    • Table 36: Diabetes Care Devices Market, Revenue ($m), China, 2002 - 2009
    • Table 37: Diabetes Care Devices Market, Revenue ($m), India, 2002 - 2009
    • Table 38: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 - 2009
    • Table 39: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 - 2009
    • Table 40: Diabetes Care Devices Market, Revenue ($m), US, 2009 - 2016
    • Table 41: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 - 2016
    • Table 42: Diabetes Care Devices Market, Revenue ($m), UK, 2009 - 2016
    • Table 43: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 - 2016
    • Table 44: Diabetes Care Devices Market, Revenue ($m), France, 2009 - 2016
    • Table 45: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 - 2016
    • Table 46: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 - 2016
    • Table 47: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 - 2016
    • Table 48: Diabetes Care Devices Market, Revenue ($m), China, 2009 - 2016
    • Table 49: Diabetes Care Devices Market, Revenue ($m), India, 2009 - 2016
    • Table 50: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 - 2016
    • Table 51: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 - 2016
    • Table 52: Glucose Monitoring Systems Pipeline Product Summary - I
    • Table 53: Glucose Monitoring Systems Pipeline Product Summary - II
    • Table 54: Glucose Monitoring Systems Pipeline Product Summary - III
    • Table 55: Home Glucose Monitoring Systems Pipeline Product Summary - I
    • Table 56: Home Glucose Monitoring Systems Pipeline Product Summary - II
    • Table 57: Hospital Setting Glucose Monitoring System Pipeline Product Summary
    • Table 58: Home and Hospital Setting Glucose Monitoring Systems Pipeline Product Summary
    • Table 59: Glucose Monitoring Systems Emerging Companies and Products- I
    • Table 60: Glucose Monitoring Systems Emerging Companies and Products - II
    • Table 61: Global Insulin Delivery Devices Pipeline Product Summary
    • Table 62: Closed-loop diabetes management system, Product Status
    • Table 63: Closed-loop diabetes management system, Product Description
    • Table 64: Paradigm Veo System, Product Status
    • Table 65: Paradigm Veo System, Product Description
    • Table 66: AERx insulin Diabetes Management System, Product Status
    • Table 67: AERx insulin Diabetes Management System, Product Description
    • Table 68: AERx insulin Diabetes Management System - Effect of Inhaled Insulin (AERx iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
    • Table 69: AERx insulin Diabetes Management System - Inhaled Pre-Prandial Human Insulin With the AERx iDMS Versus s.c. Insulin Aspart in Type 2 Diabetes: A 104 Week, Open-Label, Multicenter, Randomized, Trial Followed by a 12 Week re-Randomized Extension to Investigate Safety and Efficacy
    • Table 70: AERx insulin Diabetes Management System - Inhaled Mealtime Insulin With the AERx iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomized, Parallel Trial (Followed by a Twelve-Week Re-Randomized Extension) To Investigate Safety and Efficacy
    • Table 71: Medical Equipment, Diabetes Care Devices, Deals Summary, Q2 2008 - Q1 2009
    • Table 72: Medical Equipment, Diabetes Care Devices, Deals Summary, Q2 2008 - Q2 2009
    • Table 73: Medical Equipment, Diabetes Care Devices, Deals Summary, Q3 2008 - Q3 2009
    • Table 74: Medical Equipment, Diabetes Care Devices, Deals Summary, April 2009 - September 2009
    • Table 75: Medical Equipment, Diabetes Care Devices, Deals Summary, May 2009 - October 2009
    • Table 76: Medical Equipment, Diabetes Care Devices, Deals Summary, June 2009 - November 2009
    • Table 77: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Age Group, US, 2007
  • 1.2 List of Figures
    • Figure 1: Diabetes Care Devices, Revenue ($m), Global, 2002 - 2009
    • Figure 2: Diabetes Care Devices, Revenue ($m), Global, 2009 - 2016
    • Figure 3: Glucose Monitoring Devices, Distribution Channel Shares (%), 2008
    • Figure 4: Insulin Delivery, Distribution Channel Shares (%), 2008
    • Figure 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 - 2009
    • Figure 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 - 2015
    • Figure 7: Diabetes Incidence by Diagnosis, US, 2007
    • Figure 8: Diabetic Population by Treatment Type, US, 2007
    • Figure 9: Diabetes Care Devices, Company Share (%), Global, 2008
    • Figure 10: Glucose Monitoring, Revenue ($m), Global, 2002 - 2009
    • Figure 11: Glucose Monitoring, Revenue ($m), Global, 2009 - 2016
    • Figure 12: Blood Glucose Meters, Revenue ($m), Global, 2000 - 2009
    • Figure 13: Blood Glucose Meters, Revenue ($m), Global, 2009 - 2016
    • Figure 14: Blood Glucose Test Strips, Revenue ($m), Global, 2002 - 2009
    • Figure 15: Blood Glucose Test Strips, Revenue ($m), Global, 2009 - 2016
    • Figure 16: Insulin Delivery, Revenue ($m), Global, 2002 - 2009
    • Figure 17: Insulin Delivery, Revenue ($m), Global, 2009 - 2016
    • Figure 18: Insulin Pumps, Revenue ($m), Global, 2002 - 2009
    • Figure 19: Insulin Pumps, Revenue ($m), Global, 2009 - 2016
    • Figure 20: Insulin Pens, Revenue ($m), Global, 2002 - 2009
    • Figure 21: Insulin Pens, Revenue ($m), Global, 2009 - 2016
    • Figure 22: Insulin Syringes, Revenue ($m), Global 2002 - 2009
    • Figure 23: Insulin Syringes, Revenue ($m), Global 2009 - 2016
    • Figure 24: Strategic Competitive Assessment
    • Figure 25: Insulin Delivery Devices, Company Share Analysis (%), 2008
    • Figure 26: Glucose Monitoring, Strategic Competitive Assessment
    • Figure 27: Glucose Monitoring Systems, Company Shares - 2008
    • Figure 28: Diabetes Care Devices Market, Revenue ($m), US, 2002 - 2009
    • Figure 29: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 - 2009
    • Figure 30: Diabetes Care Devices Market, Revenue ($m), UK, 2002 - 2009
    • Figure 31: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 - 2009
    • Figure 32: Diabetes Care Devices Market, Revenue ($m), France, 2002 - 2009
    • Figure 33: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 - 2009
    • Figure 34: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 - 2009
    • Figure 35: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 - 2009
    • Figure 36: Diabetes Care Devices Market, Revenue ($m), China, 2002 - 2009
    • Figure 37: Diabetes Care Devices Market, Revenue ($m), India, 2002 - 2009
    • Figure 38: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 - 2009
    • Figure 39: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 - 2009
    • Figure 40: Diabetes Care Devices Market, Revenue ($m), US, 2009 - 2016
    • Figure 41: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 - 2016
    • Figure 42: Diabetes Care Devices Market, Revenue ($m), UK, 2009 - 2016
    • Figure 43: Diabetes Care 0044evices Market, Revenue ($m), Germany, 2009 - 2016
    • Figure 44: Diabetes Care Devices Market, Revenue ($m), France, 2009 - 2016
    • Figure 45: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 - 2016
    • Figure 46: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 - 2016
    • Figure 47: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 - 2016
    • Figure 48: Diabetes Care Devices Market, Revenue ($m), China, 2009 - 2016
    • Figure 49: Diabetes Care Devices Market, Revenue ($m), India, 2009 - 2016
    • Figure 50: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 - 2016
    • Figure 51: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 - 2016
    • Figure 52: Technology Trends Analytic Framework
    • Figure 53: Glucose Monitoring Systems - Pipeline by Clinical Phase of Development
    • Figure 54: Glucose Monitoring Systems Pipeline Product by Product Type
    • Figure 55: Strategic Competitor Assessment
    • Figure 56: Technology Trends Analytic Framework
    • Figure 57: Technology Trends Analytic Framework - Descriptions
    • Figure 58: Insulin Delivery Devices - Clinical Pipeline by Mode of Insulin Delivery
    • Figure 59: Insulin Delivery Devices Pipeline by Clinical Phase of Development
    • Figure 60: Strategic Competitor Assessment
    • Figure 61: Reimbursement for Insulin Delivery Devices
    • Figure 62: Reimbursement Mix - Insulin Pens
    • Figure 63: Medical Equipment, Diabetes Care Devices, Deal Value and Volume, Q2 2008 - Q1 2009
    • Figure 64: Medical Equipment, Diabetes Care Devices, Deal Value and Volume, Q2 2008 - Q2 2009
    • Figure 65: Medical Equipment, Diabetes Care Devices, Deal Value and No. Of Deals, Q3 2008 - Q3 2009
    • Figure 66: Diabetes Incidence by Diagnosis, US, 2007
    • Figure 67: Diabetic Population by Treatment Type, US, 2007
    • Figure 68: GBI Research Methodology